PMID- 30139549 OWN - NLM STAT- MEDLINE DCOM- 20190912 LR - 20190912 IS - 1943-7811 (Electronic) IS - 1525-1578 (Linking) VI - 20 IP - 5 DP - 2018 Sep TI - Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing. PG - 653-663 LID - S1525-1578(18)30058-8 [pii] LID - 10.1016/j.jmoldx.2018.05.007 [doi] AB - Molecular assays for translocation detection in bone and soft tissue tumors have gradually been incorporated into routine diagnostics. However, conventional methods such as fluorescence in situ hybridization (FISH) and reverse transcriptase-PCR come with several drawbacks. In this study, the applicability of a novel technique termed anchored multiplex PCR (AMP) for next-generation sequencing (NGS), using the Archer FusionPlex Sarcoma kit, aimed at 26 genes, was evaluated and compared with FISH and reverse transcriptase-PCR. In case of discrepant results, further analysis occurred with a third independent technique. Eighty-one samples were subjected to AMP-based targeted NGS, and 86% (n = 70) were successfully conducted and were either fusion positive (n = 48) or fusion negative, but met all criteria for good quality (n = 22). A concordance of 90% was found between NGS and conventional techniques. AMP-based targeted NGS showed superior results, as in four cases reverse transcriptase-PCR and FISH were false negative. Moreover, because the assay targets one partner of a gene fusion, novel or rare fusion partners can be identified. Indeed, it revealed COL1A1 and SEC31A as novel fusion partners for USP6 in nodular fasciitis. Despite the fact that fusions involving genes outside the selectively captured region cannot be detected and false-negative results due to poor quality samples can be encountered, this method has demonstrated excellent diagnostic utility for translocation detection in sarcomas. CI - Copyright (c) 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved. FAU - Lam, Suk Wai AU - Lam SW AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. FAU - Cleton-Jansen, Anne-Marie AU - Cleton-Jansen AM AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. FAU - Cleven, Arjen H G AU - Cleven AHG AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. FAU - Ruano, Dina AU - Ruano D AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. FAU - van Wezel, Tom AU - van Wezel T AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. FAU - Szuhai, Karoly AU - Szuhai K AD - Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands. FAU - Bovee, Judith V M G AU - Bovee JVMG AD - Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.v.m.g.bovee@lumc.nl. LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180820 PL - United States TA - J Mol Diagn JT - The Journal of molecular diagnostics : JMD JID - 100893612 SB - IM MH - Adolescent MH - Adult MH - Base Sequence MH - Bone Neoplasms/*genetics MH - High-Throughput Nucleotide Sequencing/*methods MH - Humans MH - Male MH - Multiplex Polymerase Chain Reaction/*methods MH - Oncogene Fusion/*genetics MH - Soft Tissue Neoplasms/*genetics MH - Young Adult EDAT- 2018/08/25 06:00 MHDA- 2019/09/13 06:00 CRDT- 2018/08/25 06:00 PHST- 2018/02/06 00:00 [received] PHST- 2018/05/03 00:00 [revised] PHST- 2018/05/15 00:00 [accepted] PHST- 2018/08/25 06:00 [entrez] PHST- 2018/08/25 06:00 [pubmed] PHST- 2019/09/13 06:00 [medline] AID - S1525-1578(18)30058-8 [pii] AID - 10.1016/j.jmoldx.2018.05.007 [doi] PST - ppublish SO - J Mol Diagn. 2018 Sep;20(5):653-663. doi: 10.1016/j.jmoldx.2018.05.007. Epub 2018 Aug 20.